Report Detail
Global Naftifine Hydrochloride API Market Growth 2022-2028
- RnM4481558 |
- 11 August, 2022 |
- Global |
- 109 Pages |
- LPI(LP Information) |
- Chemical & Material
The global market for Naftifine Hydrochloride API is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Naftifine Hydrochloride API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Naftifine Hydrochloride API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Naftifine Hydrochloride API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Naftifine Hydrochloride API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Naftifine Hydrochloride API players cover Hunan Huateng Pharmaceutical, Chongqing Huapont Pharmaceutical, Shanghai Ziyuan Pharmaceutical, Erregierre SpA and Farmak JSC, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Naftifine Hydrochloride API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Naftifine Hydrochloride API market, with both quantitative and qualitative data, to help readers understand how the Naftifine Hydrochloride API market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Tons.
Market Segmentation:
The study segments the Naftifine Hydrochloride API market and forecasts the market size by Purity (0.99, 0.995 and Others), by Application (Ointments, Gels and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by purity
0.99
0.995
Others
Segmentation by application
Ointments
Gels
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Hunan Huateng Pharmaceutical
Chongqing Huapont Pharmaceutical
Shanghai Ziyuan Pharmaceutical
Erregierre SpA
Farmak JSC
Lusochimica SPA
MSN Laboratories
Novartis Pharmaceuticals
Olon S.p.A
Sifavitor srl
Synergene Active Ingredients
Taro Pharmaceutical Industries
Chapter Introduction
Chapter 1: Scope of Naftifine Hydrochloride API, Research Methodology, etc.
Chapter 2: Executive Summary, global Naftifine Hydrochloride API market size (sales and revenue) and CAGR, Naftifine Hydrochloride API market size by region, by purity, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Naftifine Hydrochloride API sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Naftifine Hydrochloride API sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by purity, and purity.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Naftifine Hydrochloride API market size forecast by region, by country, by purity, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Hunan Huateng Pharmaceutical, Chongqing Huapont Pharmaceutical, Shanghai Ziyuan Pharmaceutical, Erregierre SpA, Farmak JSC, Lusochimica SPA, MSN Laboratories, Novartis Pharmaceuticals and Olon S.p.A, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Naftifine Hydrochloride API Annual Sales 2017-2028
- 2.1.2 World Current & Future Analysis for Naftifine Hydrochloride API by Geographic Region, 2017, 2022 & 2028
- 2.1.3 World Current & Future Analysis for Naftifine Hydrochloride API by Country/Region, 2017, 2022 & 2028
- 2.2 Naftifine Hydrochloride API Segment by Purity
- 2.2.1 0.99
- 2.2.2 0.995
- 2.2.3 Others
- 2.3 Naftifine Hydrochloride API Sales by Purity
- 2.3.1 Global Naftifine Hydrochloride API Sales Market Share by Purity (2017-2022)
- 2.3.2 Global Naftifine Hydrochloride API Revenue and Market Share by Purity (2017-2022)
- 2.3.3 Global Naftifine Hydrochloride API Sale Price by Purity (2017-2022)
- 2.4 Naftifine Hydrochloride API Segment by Application
- 2.4.1 Ointments
- 2.4.2 Gels
- 2.4.3 Others
- 2.5 Naftifine Hydrochloride API Sales by Application
- 2.5.1 Global Naftifine Hydrochloride API Sale Market Share by Application (2017-2022)
- 2.5.2 Global Naftifine Hydrochloride API Revenue and Market Share by Application (2017-2022)
- 2.5.3 Global Naftifine Hydrochloride API Sale Price by Application (2017-2022)
3 Global Naftifine Hydrochloride API by Company
- 3.1 Global Naftifine Hydrochloride API Breakdown Data by Company
- 3.1.1 Global Naftifine Hydrochloride API Annual Sales by Company (2020-2022)
- 3.1.2 Global Naftifine Hydrochloride API Sales Market Share by Company (2020-2022)
- 3.2 Global Naftifine Hydrochloride API Annual Revenue by Company (2020-2022)
- 3.2.1 Global Naftifine Hydrochloride API Revenue by Company (2020-2022)
- 3.2.2 Global Naftifine Hydrochloride API Revenue Market Share by Company (2020-2022)
- 3.3 Global Naftifine Hydrochloride API Sale Price by Company
- 3.4 Key Manufacturers Naftifine Hydrochloride API Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Naftifine Hydrochloride API Product Location Distribution
- 3.4.2 Players Naftifine Hydrochloride API Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Naftifine Hydrochloride API by Geographic Region
- 4.1 World Historic Naftifine Hydrochloride API Market Size by Geographic Region (2017-2022)
- 4.1.1 Global Naftifine Hydrochloride API Annual Sales by Geographic Region (2017-2022)
- 4.1.2 Global Naftifine Hydrochloride API Annual Revenue by Geographic Region
- 4.2 World Historic Naftifine Hydrochloride API Market Size by Country/Region (2017-2022)
- 4.2.1 Global Naftifine Hydrochloride API Annual Sales by Country/Region (2017-2022)
- 4.2.2 Global Naftifine Hydrochloride API Annual Revenue by Country/Region
- 4.3 Americas Naftifine Hydrochloride API Sales Growth
- 4.4 APAC Naftifine Hydrochloride API Sales Growth
- 4.5 Europe Naftifine Hydrochloride API Sales Growth
- 4.6 Middle East & Africa Naftifine Hydrochloride API Sales Growth
5 Americas
- 5.1 Americas Naftifine Hydrochloride API Sales by Country
- 5.1.1 Americas Naftifine Hydrochloride API Sales by Country (2017-2022)
- 5.1.2 Americas Naftifine Hydrochloride API Revenue by Country (2017-2022)
- 5.2 Americas Naftifine Hydrochloride API Sales by Purity
- 5.3 Americas Naftifine Hydrochloride API Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Naftifine Hydrochloride API Sales by Region
- 6.1.1 APAC Naftifine Hydrochloride API Sales by Region (2017-2022)
- 6.1.2 APAC Naftifine Hydrochloride API Revenue by Region (2017-2022)
- 6.2 APAC Naftifine Hydrochloride API Sales by Purity
- 6.3 APAC Naftifine Hydrochloride API Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
7 Europe
- 7.1 Europe Naftifine Hydrochloride API by Country
- 7.1.1 Europe Naftifine Hydrochloride API Sales by Country (2017-2022)
- 7.1.2 Europe Naftifine Hydrochloride API Revenue by Country (2017-2022)
- 7.2 Europe Naftifine Hydrochloride API Sales by Purity
- 7.3 Europe Naftifine Hydrochloride API Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Naftifine Hydrochloride API by Country
- 8.1.1 Middle East & Africa Naftifine Hydrochloride API Sales by Country (2017-2022)
- 8.1.2 Middle East & Africa Naftifine Hydrochloride API Revenue by Country (2017-2022)
- 8.2 Middle East & Africa Naftifine Hydrochloride API Sales by Purity
- 8.3 Middle East & Africa Naftifine Hydrochloride API Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Naftifine Hydrochloride API
- 10.3 Manufacturing Process Analysis of Naftifine Hydrochloride API
- 10.4 Industry Chain Structure of Naftifine Hydrochloride API
11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Naftifine Hydrochloride API Distributors
- 11.3 Naftifine Hydrochloride API Customer
12 World Forecast Review for Naftifine Hydrochloride API by Geographic Region
- 12.1 Global Naftifine Hydrochloride API Market Size Forecast by Region
- 12.1.1 Global Naftifine Hydrochloride API Forecast by Region (2023-2028)
- 12.1.2 Global Naftifine Hydrochloride API Annual Revenue Forecast by Region (2023-2028)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Naftifine Hydrochloride API Forecast by Purity
- 12.7 Global Naftifine Hydrochloride API Forecast by Application
13 Key Players Analysis
- 13.1 Hunan Huateng Pharmaceutical
- 13.1.1 Hunan Huateng Pharmaceutical Company Information
- 13.1.2 Hunan Huateng Pharmaceutical Naftifine Hydrochloride API Product Offered
- 13.1.3 Hunan Huateng Pharmaceutical Naftifine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.1.4 Hunan Huateng Pharmaceutical Main Business Overview
- 13.1.5 Hunan Huateng Pharmaceutical Latest Developments
- 13.2 Chongqing Huapont Pharmaceutical
- 13.2.1 Chongqing Huapont Pharmaceutical Company Information
- 13.2.2 Chongqing Huapont Pharmaceutical Naftifine Hydrochloride API Product Offered
- 13.2.3 Chongqing Huapont Pharmaceutical Naftifine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.2.4 Chongqing Huapont Pharmaceutical Main Business Overview
- 13.2.5 Chongqing Huapont Pharmaceutical Latest Developments
- 13.3 Shanghai Ziyuan Pharmaceutical
- 13.3.1 Shanghai Ziyuan Pharmaceutical Company Information
- 13.3.2 Shanghai Ziyuan Pharmaceutical Naftifine Hydrochloride API Product Offered
- 13.3.3 Shanghai Ziyuan Pharmaceutical Naftifine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.3.4 Shanghai Ziyuan Pharmaceutical Main Business Overview
- 13.3.5 Shanghai Ziyuan Pharmaceutical Latest Developments
- 13.4 Erregierre SpA
- 13.4.1 Erregierre SpA Company Information
- 13.4.2 Erregierre SpA Naftifine Hydrochloride API Product Offered
- 13.4.3 Erregierre SpA Naftifine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.4.4 Erregierre SpA Main Business Overview
- 13.4.5 Erregierre SpA Latest Developments
- 13.5 Farmak JSC
- 13.5.1 Farmak JSC Company Information
- 13.5.2 Farmak JSC Naftifine Hydrochloride API Product Offered
- 13.5.3 Farmak JSC Naftifine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.5.4 Farmak JSC Main Business Overview
- 13.5.5 Farmak JSC Latest Developments
- 13.6 Lusochimica SPA
- 13.6.1 Lusochimica SPA Company Information
- 13.6.2 Lusochimica SPA Naftifine Hydrochloride API Product Offered
- 13.6.3 Lusochimica SPA Naftifine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.6.4 Lusochimica SPA Main Business Overview
- 13.6.5 Lusochimica SPA Latest Developments
- 13.7 MSN Laboratories
- 13.7.1 MSN Laboratories Company Information
- 13.7.2 MSN Laboratories Naftifine Hydrochloride API Product Offered
- 13.7.3 MSN Laboratories Naftifine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.7.4 MSN Laboratories Main Business Overview
- 13.7.5 MSN Laboratories Latest Developments
- 13.8 Novartis Pharmaceuticals
- 13.8.1 Novartis Pharmaceuticals Company Information
- 13.8.2 Novartis Pharmaceuticals Naftifine Hydrochloride API Product Offered
- 13.8.3 Novartis Pharmaceuticals Naftifine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.8.4 Novartis Pharmaceuticals Main Business Overview
- 13.8.5 Novartis Pharmaceuticals Latest Developments
- 13.9 Olon S.p.A
- 13.9.1 Olon S.p.A Company Information
- 13.9.2 Olon S.p.A Naftifine Hydrochloride API Product Offered
- 13.9.3 Olon S.p.A Naftifine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.9.4 Olon S.p.A Main Business Overview
- 13.9.5 Olon S.p.A Latest Developments
- 13.10 Sifavitor srl
- 13.10.1 Sifavitor srl Company Information
- 13.10.2 Sifavitor srl Naftifine Hydrochloride API Product Offered
- 13.10.3 Sifavitor srl Naftifine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.10.4 Sifavitor srl Main Business Overview
- 13.10.5 Sifavitor srl Latest Developments
- 13.11 Synergene Active Ingredients
- 13.11.1 Synergene Active Ingredients Company Information
- 13.11.2 Synergene Active Ingredients Naftifine Hydrochloride API Product Offered
- 13.11.3 Synergene Active Ingredients Naftifine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.11.4 Synergene Active Ingredients Main Business Overview
- 13.11.5 Synergene Active Ingredients Latest Developments
- 13.12 Taro Pharmaceutical Industries
- 13.12.1 Taro Pharmaceutical Industries Company Information
- 13.12.2 Taro Pharmaceutical Industries Naftifine Hydrochloride API Product Offered
- 13.12.3 Taro Pharmaceutical Industries Naftifine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.12.4 Taro Pharmaceutical Industries Main Business Overview
- 13.12.5 Taro Pharmaceutical Industries Latest Developments
14 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Naftifine Hydrochloride API. Industry analysis & Market Report on Naftifine Hydrochloride API is a syndicated market report, published as Global Naftifine Hydrochloride API Market Growth 2022-2028
. It is complete Research Study and Industry Analysis of Naftifine Hydrochloride API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
